Fig. 5
From: Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
The evaluation of prognostic ability of TFs-based signature. A, B Kaplan-Merier survival curve of training set and validation set showed patients with higher risk have significantly worse clinical outcome. C Time-dependent ROC curves were conducted, and the TFs-based signature elevated the prognostic accuracy both in training and validation cohort. D Heatmap showed expression profile of 6 TFs in high-risk and low-risk groups